354 related articles for article (PubMed ID: 16024790)
1. NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release.
Di Marco S; Mazroui R; Dallaire P; Chittur S; Tenenbaum SA; Radzioch D; Marette A; Gallouzi IE
Mol Cell Biol; 2005 Aug; 25(15):6533-45. PubMed ID: 16024790
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear factor kappa B in cytokine-induced nitric oxide and tetrahydrobiopterin synthesis in rat neonatal cardiac myocytes.
Hattori Y; Nakanishi N; Kasai K
J Mol Cell Cardiol; 1997 Jun; 29(6):1585-92. PubMed ID: 9220344
[TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional regulation of the human inducible nitric oxide synthase (iNOS) expression by the cytosolic poly(A)-binding protein (PABP).
Casper I; Nowag S; Koch K; Hubrich T; Bollmann F; Henke J; Schmitz K; Kleinert H; Pautz A
Nitric Oxide; 2013 Sep; 33():6-17. PubMed ID: 23711718
[TBL] [Abstract][Full Text] [Related]
5. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages.
Lahti A; Jalonen U; Kankaanranta H; Moilanen E
Mol Pharmacol; 2003 Aug; 64(2):308-15. PubMed ID: 12869635
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
Guttridge DC; Mayo MW; Madrid LV; Wang CY; Baldwin AS
Science; 2000 Sep; 289(5488):2363-6. PubMed ID: 11009425
[TBL] [Abstract][Full Text] [Related]
7. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
8. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.
Hattori Y; Nakanishi N; Kasai K
Cardiovasc Res; 2002 Jun; 54(3):649-58. PubMed ID: 12031711
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and tumor necrosis factor-alpha production by oleanolic acid via nuclear factor-kappaB activation in macrophages.
Choi CY; You HJ; Jeong HG
Biochem Biophys Res Commun; 2001 Oct; 288(1):49-55. PubMed ID: 11594750
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen inhibits iNOS gene expression in RAW 264.7 macrophages: differential regulation of NF-kappaB by acetaminophen and salicylates.
Ryu YS; Lee JH; Seok JH; Hong JH; Lee YS; Lim JH; Kim YM; Hur GM
Biochem Biophys Res Commun; 2000 Jun; 272(3):758-64. PubMed ID: 10860828
[TBL] [Abstract][Full Text] [Related]
11. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
12. Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia.
Huang C; Lu X; Tong L; Wang J; Zhang W; Jiang B; Yang R
J Neuroinflammation; 2015 Oct; 12():189. PubMed ID: 26467650
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells.
Datta PK; Lianos EA
Kidney Int; 1999 Aug; 56(2):486-93. PubMed ID: 10432387
[TBL] [Abstract][Full Text] [Related]
15. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells.
Kim YM; Paik SG
Biochem Biophys Res Commun; 2005 Jan; 326(2):410-6. PubMed ID: 15582593
[TBL] [Abstract][Full Text] [Related]
16. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI; Eizirik DL
Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
[TBL] [Abstract][Full Text] [Related]
17. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR.
Linker K; Pautz A; Fechir M; Hubrich T; Greeve J; Kleinert H
Nucleic Acids Res; 2005; 33(15):4813-27. PubMed ID: 16126846
[TBL] [Abstract][Full Text] [Related]
18. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.
Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ
J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322
[TBL] [Abstract][Full Text] [Related]
19. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
[TBL] [Abstract][Full Text] [Related]
20. Catalase induces the expression of inducible nitric oxide synthase through activation of NF-kappaB and PI3K signaling pathway in Raw 264.7 cells.
Jang BC; Paik JH; Kim SP; Bae JH; Mun KC; Song DK; Cho CH; Shin DH; Kwon TK; Park JW; Park JG; Baek WK; Suh MH; Lee SH; Baek SH; Lee IS; Suh SI
Biochem Pharmacol; 2004 Dec; 68(11):2167-76. PubMed ID: 15498507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
